French Development Agency Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02348177
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

lopinavir (Kaletra) (2 trials)

ritonavir (Norvir) (2 trials)

Drugs in Phase 3 Trials (3)

abacavir (ziagen) (1 trial)

lamivudine (epivir) (1 trial)

zidovudine (retrovir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

HIV Infections (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5